Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 27 Leukemia 16 Lung Neoplasms 13 Neuroblastoma 12 Burkitt Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 10 Hodgkin Disease 10 Sarcoma 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Central Nervous System Neoplasms 9 Brain Neoplasms 9 Teratoma 8 Carcinoma, Non-Small-Cell Lung 7 Wilms Tumor 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Leukemia, Myeloid, Acute 6 Testicular Neoplasms 5 Lymphoma, Non-Hodgkin 5 Ovarian Neoplasms 4 Medulloblastoma 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Endodermal Sinus Tumor 4 Dendritic Cell Sarcoma, Interdigitating 4 Carcinoma, Embryonal 4 Sarcoma, Ewing 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Paclitaxel 2 Nelfinavir 2 nirogacestat 1 liposomal doxorubicin 1 ixazomib 1 emvododstat 1 Valproic Acid 1 Sirolimus 1 Semaxinib 1 Saquinavir 1 Ritonavir 1 Propranolol 1 Polymerase Chain Reaction 1 Palliative Care 1 Nutritional Support 1 Indinavir 1 Immunohistochemistry 1 Imatinib Mesylate 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 Daunorubicin 1 Celecoxib 1 Biopsy 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Sarcoma, Kaposi × Etoposide × Clear all

NCT01352117 2019-11-14

REACT-KS

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Phase 3 Completed

192 enrolled 35 charts

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡